GlaxoSmithKline Pharmaceuticals Ltd GLAXO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹2,725.90
- Day Range
- ₹2,711.25–2,765.65
- 52-Week Range
- ₹1,385.05–3,088.00
- Bid/Ask
- ₹2,727.25 / ₹2,590.90
- Market Cap
- ₹462.01 Bil
- Volume/Avg
- 13 / 127,888
Key Statistics
- Price/Earnings (Normalized)
- 70.95
- Price/Sales
- 13.22
- Dividend Yield (Trailing)
- 1.17%
- Dividend Yield (Forward)
- 1.17%
- Total Yield
- 1.17%
Company Profile
GlaxoSmithKline Pharmaceuticals Ltd is an India-based subsidiary of GlaxoSmithKline plc. GSK India develops and manufactures medicines, vaccines, and consumer products. Its medicines portfolio includes prescription drugs for conditions that include asthma, infectious diseases, mental health, and digestion, as well as nonprescription nutrition and cosmetic products. Its vaccines product line includes treatments for conditions such as influenza, HPV, hepatitis, and measles. Its consumer healthcare products include Horlicks-brand packaged food and beverage powders among other retail products. The company derives majority of its revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Growth
- Total Number of Employees
- 3,211
- Website
- https://www.gsk-india.com
Comparables
Valuation
|
Metric
|
GLAXO
|
500257
|
532612
|
|---|---|---|---|
Price/Earnings (Normalized) | 70.95 | 40.85 | 58.70 |
Price/Book Value | 25.86 | 7.03 | 3.04 |
Price/Sales | 13.22 | 4.90 | 1.87 |
Price/Cash Flow | 88.99 | 30.49 | 16.20 |
Price/Earnings
GLAXO
500257
532612
Financial Strength
|
Metric
|
GLAXO
|
500257
|
532612
|
|---|---|---|---|
Quick Ratio | 1.45 | 0.95 | 0.74 |
Current Ratio | 1.84 | 1.58 | 1.56 |
Interest Coverage | 433.44 | 11.75 | 3.41 |
Quick Ratio
GLAXO
500257
532612
Profitability
|
Metric
|
GLAXO
|
500257
|
532612
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
GLAXO
500257
532612
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Lgmhtbsmp | Dft | $818.8 Bil | |||
| Johnson & Johnson
JNJ
| Lytckpjf | Dys | $388.5 Bil | |||
| AbbVie Inc
ABBV
| Dbcyxdqr | Fqd | $339.0 Bil | |||
| Merck & Co Inc
MRK
| Dvllqpr | Lyzwb | $286.7 Bil | |||
| Roche Holding AG ADR
RHHBY
| Rrzlcrtvy | Crgn | $255.9 Bil | |||
| AstraZeneca PLC ADR
AZN
| Bsscpbvxv | Bddc | $241.9 Bil | |||
| Novartis AG ADR
NVS
| Qrpjhhy | Gbvrs | $233.0 Bil | |||
| Amgen Inc
AMGN
| Pxjvdpffm | Czypl | $171.5 Bil | |||
| Pfizer Inc
PFE
| Fxfgfbqq | Kdv | $164.2 Bil | |||
| Sanofi SA ADR
SNY
| Dmgvmymw | Cvfmp | $142.8 Bil |
United States